The PPAR-γ antagonist T007 inhibits RANKL-induced osteoclastogenesis and counteracts OVX-induced bone loss in mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The PPAR-γ antagonist T007 inhibits RANKL-induced osteoclastogenesis and counteracts OVX-induced bone loss in mice
Authors
Keywords
-
Journal
Cell Communication and Signaling
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-27
DOI
10.1186/s12964-019-0442-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peroxisome proliferator-activated receptor γ plays dual roles on experimental periodontitis in rats
- (2018) Weiwei Qiao et al. JOURNAL OF CLINICAL PERIODONTOLOGY
- Iguratimod prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis via inhibition of peroxisome proliferator-activated receptor-γ
- (2017) Ying-Xing Wu et al. Molecular Medicine Reports
- Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD
- (2017) Mathias Haarhaus et al. Nature Reviews Nephrology
- The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss
- (2017) Ting Zheng et al. Oncotarget
- OPG rs2073617 polymorphism is associated with upregulated OPG protein expression and an increased risk of intervertebral disc degeneration
- (2016) Jing-Bo Xue et al. Experimental and Therapeutic Medicine
- High-Fat Diet Causes Bone Loss in Young Mice by Promoting Osteoclastogenesis Through Alteration of the Bone Marrow Environment
- (2015) Lei Shu et al. CALCIFIED TISSUE INTERNATIONAL
- HDAC9 Inhibits Osteoclastogenesis via Mutual Suppression of PPARγ/RANKL Signaling
- (2015) Zixue Jin et al. MOLECULAR ENDOCRINOLOGY
- The Role of PPAR Gamma in Systemic Sclerosis
- (2015) Andréa Tavares Dantas et al. PPAR Research
- Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo
- (2015) Shuai Chen et al. Scientific Reports
- Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis
- (2015) Chang Liu et al. Scientific Reports
- Phylogenetic diversity of culturable fungi in the Heshang Cave, central China
- (2015) Baiying Man et al. Frontiers in Microbiology
- Peroxisome Proliferator-Activated Receptor-γ Inhibits Transformed Growth of Non-Small Cell Lung Cancer Cells through Selective Suppression of Snail
- (2015) Rashmi Choudhary et al. NEOPLASIA
- Liquid-based cytology and human papillomavirus testing: A pooled analysis using the data from 13 population-based cervical cancer screening studies from China
- (2014) Qin-jing Pan et al. GYNECOLOGIC ONCOLOGY
- A review of denosumab for the treatment of osteoporosis
- (2014) Tsuyoshi Miyazaki et al. Patient Preference and Adherence
- The Peroxisome Proliferator-Activated Receptor γ Agonist Pioglitazone Preserves Bone Microarchitecture in Experimental Arthritis by Reducing the Interleukin-17-Dependent Osteoclastogenic Pathway
- (2013) Meriem Koufany et al. ARTHRITIS AND RHEUMATISM
- The impact of decreasing U.S. hip fracture rates on future hip fracture estimates
- (2013) J. A. Stevens et al. OSTEOPOROSIS INTERNATIONAL
- Signaling Networks that Control the Lineage Commitment and Differentiation of Bone Cells
- (2012) Carrie S. Soltanoff et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation
- (2012) Guiqian Chen et al. International Journal of Biological Sciences
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
- (2012) David L. Lacey et al. NATURE REVIEWS DRUG DISCOVERY
- Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice
- (2011) Sun Wook Cho et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats
- (2011) Qi-Guang Mai et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation
- (2011) Markus C. Kühn et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Mosaicism in Osteopathia Striata with Cranial Sclerosis
- (2010) Dennis J. Joseph et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression
- (2010) Liangming Zhang et al. JOURNAL OF PINEAL RESEARCH
- PPARγ in bone homeostasis
- (2010) Yihong Wan TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Functions of RANKL/RANK/OPG in bone modeling and remodeling
- (2008) Brendan F. Boyce et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP)
- (2007) Kabsun Kim et al. MOLECULAR ENDOCRINOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now